A researcher’s guide to Key Driver Analysis
Research Manager Kayleigh Simpson explores how Key Driver Analysis can be used to answer key business questions
During my time as a healthcare market researcher I’ve learned that there are three key business questions that are critical to marketing success - Which product features drive the prescribing of a product? Which are the most important factors that influence likelihood to use a product that’s soon to be launched? Finally, what factors drive brand satisfaction and consumer loyalty? If you can confidently answer these questions then you’re on the road to success. The good news – there’s an analytical process that answers all these questions.
Emotional Recognition using Facial Analysis
Do you have a poker face or does your expression give you away? According to psychologists, a lot of emotional information can be drawn from our facial expressions, which is valuable to us as market researchers as we are interested in the emotional responses driving people’s attitudes and behaviours. We recently partnered with a tech company called Affectiva which has analysed over 5 million faces and 24,000 adverts to understand how people respond to digital stimulus such as advertising, websites and apps. Our client wanted to understand physicians’ response to communications materials designed for a disease awareness campaign, so their technology was ideal for the project’s objective.
The value of design thinking: Incorporating creative and graphic design into pharma market research
How do we keep research design fresh and interesting? How do we ensure that we’re inspiring our respondents to give us enlightening new insights, and encourage new ways of thinking?
There is a strong precedent for incorporating ‘design thinking’ into methods for improving aspects of healthcare delivery, particularly now that there is a greater emphasis on patient centricity and improving the customer experience. A great story of design in product development comes from Doug Dietz, a principle designer for GE Healthcare. After spending two years designing a new MRI scanner, he was excited to see it in action. But at the hospital, as he observed a young family with a child approaching, he realised that the child was terrified.
Blending qual and quant – the benefits of a hybrid approach
My colleague Chris Gaj and I recently conducted a video dialogue on the topic of hybrid qual/quant methods in which we discussed why clients often want to blend the two, and the best approaches for obtaining qualitative insights with quantitative precision. A typical case would be in-licensing opportunity assessments, which usually require a fast turnaround. The objective of this type of study is to quantify the revenue potential of a possible new asset and ideally provide some depth of insight to support a go/no decision. In other words, answer the key questions: how much? And why?
In the news: What will the UK’s recent general election result and ongoing Brexit negotiations mean for DfID funding for global health?
The UK’s Department for International Development (DfID) was established in 1997 with a mandate to tackle world poverty. Since its inception, it has played a major role in the global health landscape through bilateral programs, health partnerships, and the support of multilateral organisations, as well as influencing global health policy and international health research. Its future has come under increasing scrutiny following the UK referendum result in favour of leaving the EU last year, and again in the wake of last month’s general election result.